Technology News

Siemens Healthineers Receives FDA Premarket Approval of HCV Genotyping Test for Hepatitis C Patients
VERSANT® HCV Genotype 2.0 Assay (LiPA) provides improved accuracy in identification of HCV genotype and subtype for guiding selection of optimal therapeutic treatment for individuals with Hepatitis C
| 2 min read

















